New insight into transdermal drug delivery with supersaturated formulation based on co-amorphous system

Yuya Hirakawa, Hiroshi Ueda, Tetsuya Miyano, Noriho Kamiya, Masahiro Goto

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The objective of this study was to prepare a supersaturated formulation based on formation of a co-amorphous system of a drug and a coformer in order to enhance skin permeation. Atenolol (ATE) and urea (URE) were used as the model drug and the coformer, respectively. Thermal analysis of physical mixtures of ATE and URE showed decreases in the melting points and the formation of a co-amorphous system which was in a supercooled liquid state because of a low glass transition temperature. Supersaturated solutions of ATE and URE at different molar ratios in polyethylene glycol 400 (PEG400) were prepared. The precipitations were observed under storage at 25 °C for all formulations except for ATE-URE at 1:8 molar ratio which remained in the supersaturated state for 2 months. 1H NMR analysis confirmed the interactions between ATE and URE in PEG400. The ATE-URE supersaturated formulation showed higher permeability for mice skin than that of ATE saturated formulation, which was superior to the expected permeability from the degree of supersaturation. We concluded that co-amorphous based supersaturated formulation offers much promise for transdermal drug delivery.

Original languageEnglish
Article number118582
JournalInternational Journal of Pharmaceutics
Volume569
DOIs
Publication statusPublished - Oct 5 2019

Fingerprint

Atenolol
Urea
Pharmaceutical Preparations
Permeability
Skin
Transition Temperature
Freezing
Glass
Hot Temperature

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

New insight into transdermal drug delivery with supersaturated formulation based on co-amorphous system. / Hirakawa, Yuya; Ueda, Hiroshi; Miyano, Tetsuya; Kamiya, Noriho; Goto, Masahiro.

In: International Journal of Pharmaceutics, Vol. 569, 118582, 05.10.2019.

Research output: Contribution to journalArticle

@article{77b795ee4ace4af79ce5b5da4fa4819e,
title = "New insight into transdermal drug delivery with supersaturated formulation based on co-amorphous system",
abstract = "The objective of this study was to prepare a supersaturated formulation based on formation of a co-amorphous system of a drug and a coformer in order to enhance skin permeation. Atenolol (ATE) and urea (URE) were used as the model drug and the coformer, respectively. Thermal analysis of physical mixtures of ATE and URE showed decreases in the melting points and the formation of a co-amorphous system which was in a supercooled liquid state because of a low glass transition temperature. Supersaturated solutions of ATE and URE at different molar ratios in polyethylene glycol 400 (PEG400) were prepared. The precipitations were observed under storage at 25 °C for all formulations except for ATE-URE at 1:8 molar ratio which remained in the supersaturated state for 2 months. 1H NMR analysis confirmed the interactions between ATE and URE in PEG400. The ATE-URE supersaturated formulation showed higher permeability for mice skin than that of ATE saturated formulation, which was superior to the expected permeability from the degree of supersaturation. We concluded that co-amorphous based supersaturated formulation offers much promise for transdermal drug delivery.",
author = "Yuya Hirakawa and Hiroshi Ueda and Tetsuya Miyano and Noriho Kamiya and Masahiro Goto",
year = "2019",
month = "10",
day = "5",
doi = "10.1016/j.ijpharm.2019.118582",
language = "English",
volume = "569",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier",

}

TY - JOUR

T1 - New insight into transdermal drug delivery with supersaturated formulation based on co-amorphous system

AU - Hirakawa, Yuya

AU - Ueda, Hiroshi

AU - Miyano, Tetsuya

AU - Kamiya, Noriho

AU - Goto, Masahiro

PY - 2019/10/5

Y1 - 2019/10/5

N2 - The objective of this study was to prepare a supersaturated formulation based on formation of a co-amorphous system of a drug and a coformer in order to enhance skin permeation. Atenolol (ATE) and urea (URE) were used as the model drug and the coformer, respectively. Thermal analysis of physical mixtures of ATE and URE showed decreases in the melting points and the formation of a co-amorphous system which was in a supercooled liquid state because of a low glass transition temperature. Supersaturated solutions of ATE and URE at different molar ratios in polyethylene glycol 400 (PEG400) were prepared. The precipitations were observed under storage at 25 °C for all formulations except for ATE-URE at 1:8 molar ratio which remained in the supersaturated state for 2 months. 1H NMR analysis confirmed the interactions between ATE and URE in PEG400. The ATE-URE supersaturated formulation showed higher permeability for mice skin than that of ATE saturated formulation, which was superior to the expected permeability from the degree of supersaturation. We concluded that co-amorphous based supersaturated formulation offers much promise for transdermal drug delivery.

AB - The objective of this study was to prepare a supersaturated formulation based on formation of a co-amorphous system of a drug and a coformer in order to enhance skin permeation. Atenolol (ATE) and urea (URE) were used as the model drug and the coformer, respectively. Thermal analysis of physical mixtures of ATE and URE showed decreases in the melting points and the formation of a co-amorphous system which was in a supercooled liquid state because of a low glass transition temperature. Supersaturated solutions of ATE and URE at different molar ratios in polyethylene glycol 400 (PEG400) were prepared. The precipitations were observed under storage at 25 °C for all formulations except for ATE-URE at 1:8 molar ratio which remained in the supersaturated state for 2 months. 1H NMR analysis confirmed the interactions between ATE and URE in PEG400. The ATE-URE supersaturated formulation showed higher permeability for mice skin than that of ATE saturated formulation, which was superior to the expected permeability from the degree of supersaturation. We concluded that co-amorphous based supersaturated formulation offers much promise for transdermal drug delivery.

UR - http://www.scopus.com/inward/record.url?scp=85070557301&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070557301&partnerID=8YFLogxK

U2 - 10.1016/j.ijpharm.2019.118582

DO - 10.1016/j.ijpharm.2019.118582

M3 - Article

C2 - 31381987

AN - SCOPUS:85070557301

VL - 569

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

M1 - 118582

ER -